Mapping genomic loci implicates genes and synaptic biology in schizophrenia
2022 · Nature · 2,628 citations
https://doi.org/10.1038/s41586-022-04434-5
M
Matthias Rothermundt
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
135
Papers
9.3K
Citations
48
h-index
89
i10-index
Matthias Rothermundt is an academic researcher from University of Münster. The author has contributed to research in topics: Tryptophan and brain disorders & S100 Proteins and Annexins & Schizophrenia research and treatment. The author has an h-index of 48, co-authored 115 publications.
Papers by this author
worksS100B in brain damage and neurodegeneration
2003 · Microscopy Research and Technique · 607 citations
https://doi.org/10.1002/jemt.10303
Serum proteomic profiling of major depressive disorder
2015 · Translational Psychiatry · 134 citations
https://doi.org/10.1038/tp.2015.88
S-100B is increased in melancholic but not in non-melancholic major depression
2001 · Journal of Affective Disorders · 100 citations
https://doi.org/10.1016/s0165-0327(00)00321-9
Identification of Subgroups of Schizophrenia Patients With Changes in Either Immune or Growth Factor and Hormonal Pathways
2013 · Schizophrenia Bulletin · 98 citations
https://doi.org/10.1093/schbul/sbt105
The astroglial protein S100B and visually evoked event-related potentials before and after antidepressant treatment
2004 · Psychopharmacology · 89 citations
https://doi.org/10.1007/s00213-004-1999-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat